{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:13:45Z","timestamp":1792642425056,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00182"],"award-info":[{"award-number":["PI14\/00182"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00298"],"award-info":[{"award-number":["PI17\/00298"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008318","name":"Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jhep.2020.01.008","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:27:00Z","timestamp":1579692420000},"page":"774-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Precision medicine in variceal bleeding: Are we there yet?"],"prefix":"10.1016","volume":"72","author":[{"given":"Marta","family":"Magaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Baiges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hern\u00e1ndez-Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","article-title":"A\u00a0MELD-based model to determine risk of mortality among patients with acute variceal bleeding","volume":"146","author":"Reverter","year":"2014","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jhep.2020.01.008_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2020.01.008_bib4","first-page":"1318","article-title":"Beta-blockers to prevent gastroesophageal varices in cirrhosis","volume":"354","author":"Groszmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2015.07.001","article-title":"Individualized care for portal hypertension: not quite yet","volume":"63","author":"Kamath","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2020.01.008_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A\u00a0model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/00365521.2011.645500","article-title":"Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis","volume":"47","author":"Ripoll","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0950-3528(97)90038-5","article-title":"Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding","volume":"11","author":"D'Amico","year":"1997","journal-title":"Baillieres Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.008_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0168-8278(03)00011-4","article-title":"Evaluation and follow-up of patients with cirrhosis and oesophageal varices","volume":"38","author":"de Franchis","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cld.2014.01.002","article-title":"Management of gastric varices","volume":"18","author":"Henry","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study","volume":"111","author":"Vorobioff","year":"1996","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.jhep.2020.01.008_bib18","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.24418","article-title":"Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis","volume":"54","author":"Berzigotti","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.28992","article-title":"Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study","volume":"65","author":"Berzigotti","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.008_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00535-010-0360-z","article-title":"Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension","volume":"46","author":"Berzigotti","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.008_bib22","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension. Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.jhep.2020.01.008_bib25","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/S0168-8278(15)30025-8","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The \u201cAnticipate\u201d study","volume":"62","author":"Abraldes","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.gastro.2018.11.053","article-title":"Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy","volume":"156","author":"Thabut","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00535-019-01619-0","article-title":"Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV\u2013cirrhotic patients","volume":"55","author":"Puigveh\u00ed","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.008_bib28","article-title":"Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy","author":"Mandorfer","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.008_bib29","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis","volume":"153","author":"Lens","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.01.008_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12876-015-0414-z","article-title":"Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study","volume":"15","author":"Zykus","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/radiol.2015150690","article-title":"Portal hypertension in patients with liver cirrhosis: diagnostic accuracy of spleen stiffness","volume":"279","author":"Takuma","year":"2016","journal-title":"Radiology"},{"issue":"10181","key":"10.1016\/j.jhep.2020.01.008_bib33","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.dld.2016.09.013","article-title":"Beta blockers and cirrhosis, 2016","volume":"49","author":"Mandorfer","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","article-title":"A\u00a0placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis","volume":"127","author":"Merkel","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-012-9353-8","article-title":"Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial","volume":"7","author":"Sarin","year":"2013","journal-title":"Hepatol Int"},{"issue":"10","key":"10.1016\/j.jhep.2020.01.008_bib37","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/gutjnl-2016-311735","article-title":"Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial","volume":"66","author":"Bhardwaj","year":"2016","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-2008-1040614","article-title":"Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment","volume":"6","author":"Polio","year":"1986","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.01.008_bib41","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","article-title":"Prevention of variceal rebleeding","volume":"361","author":"Bosch","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib42","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/hep.30220","article-title":"Comparison of therapies for primary prevention of esophageal variceal bleeding: a systematic review and network meta-analysis","volume":"69","author":"Sharma","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jhep.2020.01.008_bib43","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.008_bib44","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.01.008_bib45","first-page":"349","article-title":"The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis","volume":"13","author":"Merkel","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.008_bib46","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/hep.1840360611","article-title":"\u201cA la carte\u201d treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding","volume":"36","author":"Bureau","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1572-0241.2006.00453.x","article-title":"Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis","volume":"101","author":"Turnes","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2009.04.015","article-title":"Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension","volume":"51","author":"La Mura","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"April 2011","key":"10.1016\/j.jhep.2020.01.008_bib50","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ajg.2011.456","article-title":"Development of ascites in compensated cirrhosis with severe portal hypertension treated with \u03b2-blockers","volume":"107","author":"Hern\u00e1ndez-Gea","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jceh.2016.01.004","article-title":"Hemodynamic response to carvedilol is maintained for long periods and leads to better clinical outcome in cirrhosis: a prospective study: acute hemodynamic response to carvedilol","volume":"6","author":"Kirnake","year":"2016","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib52","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.25686","article-title":"Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding","volume":"56","author":"Augustin","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib53","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2006-951603","article-title":"Measurement of portal pressure and its role in the management of chronic liver disease","volume":"26","author":"Bosch","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gastrohep.2009.04.002","article-title":"Trombosis portal","volume":"33","author":"Seijo-R\u00edos","year":"2010","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib56","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1572-0241.2004.40665.x","article-title":"Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose","volume":"100","author":"Villanueva","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib57","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2011.11.019","article-title":"Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial","volume":"56","author":"Azam","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5946\/ce.2018.084","article-title":"The use of vasoconstrictors in acute variceal bleeding: how long is enough?","volume":"52","author":"Lo","year":"2019","journal-title":"Clin Endosc"},{"issue":"41","key":"10.1016\/j.jhep.2020.01.008_bib59","doi-asserted-by":"crossref","first-page":"e12826","DOI":"10.1097\/MD.0000000000012826","article-title":"Is additional 5-day vasoactive drug therapy necessary for acute variceal bleeding after successful endoscopic hemostasis? A systematic review and meta-analysis","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0016-5085(99)70455-5","article-title":"Prognostic value of early measurements of portal pressure in acute variceal bleeding","volume":"117","author":"Moitinho","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2007.10.008","article-title":"Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy","volume":"48","author":"Abraldes","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.01.008_bib62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/gast.2001.25536","article-title":"Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding","volume":"121","author":"Villanueva","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0038-1676805","article-title":"Child-pugh classification: time to abandon?","volume":"39","author":"Kok","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib64","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/liv.13632","article-title":"Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding","volume":"38","author":"Rudler","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2017.04.042","article-title":"Multicenter external validation of risk stratification criteria for patients with variceal bleeding","volume":"16","author":"Conejo","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2020.01.008_bib66","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.01.008_bib67","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhep.2020.01.008_bib68","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","article-title":"Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial","volume":"4","author":"Lv","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"25","key":"10.1016\/j.jhep.2020.01.008_bib69","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garc\u00eda-Pag\u00e1n","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.008_bib70","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1111\/tri.12090","article-title":"Salvage transjugular intrahepatic portosystemic shunt followed by early transplantation in patients with Child C14-15 cirrhosis and refractory variceal bleeding: a strategy improving survival","volume":"26","author":"Rudler","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2020.01.008_bib71","article-title":"Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study","author":"Lv","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhep.2017.09.002","article-title":"Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results","volume":"68","author":"Thabut","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","article-title":"Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study","volume":"58","author":"Garcia-Pag\u00e1n","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study","volume":"69","author":"Hern\u00e1ndez-Gea","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.008_bib75","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2014.11.019","article-title":"Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class and effects of antibiotics","volume":"13","author":"Tandon","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.008_bib76","series-title":"Portal Hypertension in the 21st CenturyDordrecht","first-page":"147","article-title":"Esophageal varices: from appearance to rupture; natural history and prognostic indicators","author":"D'Amico","year":"2004"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0168-8278(01)00307-5","article-title":"Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study [N Engl J Med 1981;305:1371\u20131374]","volume":"36","author":"Pagliaro","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"25","key":"10.1016\/j.jhep.2020.01.008_bib78","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJM199606203342502","article-title":"Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding","volume":"334","author":"Villanueva","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jhep.2020.01.008_bib79","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.cgh.2009.08.011","article-title":"Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis","volume":"7","author":"Augustin","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib80","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.29267","article-title":"Stratifying risk in the prevention of recurrent variceal hemorrhage: results of an individual patient meta-analysis","volume":"66","author":"Albillos","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.008_bib81","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","author":"Abraldes","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.008_bib82","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2004.01.017","article-title":"Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis","volume":"40","author":"Villanueva","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib84","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.1840110212","article-title":"Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis","volume":"11","author":"Garcia-Pag\u00e1n","year":"1990","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhep.2020.01.008_bib85","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-114-10-869","article-title":"Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study","volume":"114","author":"Garc\u00eda-Pag\u00e1n","year":"1991","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2009.10.014","article-title":"Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria","volume":"52","author":"Merkel","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.008_bib87","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/hep.29056","article-title":"A\u00a0randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis","volume":"65","author":"Villanueva","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2036.2008.03880.x","article-title":"Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol\u00a0+ ligation vs. hepatic venous pressure gradient-guided pharmacological therapy","volume":"29","author":"Villanueva","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jhep.2020.01.008_bib89","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gut.2008.171207","article-title":"Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial","volume":"58","author":"Garc\u00eda-Pag\u00e1n","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0016-5085(98)70372-5","article-title":"Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension","volume":"115","author":"Albillos","year":"1998","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib91","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0016-5085(95)90586-3","article-title":"Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function","volume":"109","author":"Albillos","year":"1995","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.008_bib92","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2014.06.015","article-title":"Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding","volume":"61","author":"Stanley","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2020.01.008_bib93","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","article-title":"Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding","volume":"27","author":"Lo","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.008_bib94","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib95","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/liv.14042","article-title":"Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis","volume":"39","author":"Reverter","year":"2019","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.008_bib96","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2016.01.022","article-title":"Assessment of response to beta-blockers by expression of \u03b2Arr2 and RhoA\/ROCK2 in antrum mucosa in cirrhotic patients","volume":"64","author":"Trebicka","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2020.01.008_bib97","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective beta-blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.008_bib98","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2011.01.034","article-title":"Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study","volume":"55","author":"Serst\u00e9","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib99","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serst\u00e9","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.008_bib100","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.28352","article-title":"Nonselective beta-blockers do not affect mortality in cirrhosis patients with ascites: post Hoc analysis of three randomized controlled trials with 1198 patients","volume":"63","author":"Bossen","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhep.2020.01.008_bib101","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jhep.2020.01.008_bib102","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cgh.2016.01.012","article-title":"Nonselective \u03b2-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis","volume":"14","author":"Chirapongsathorn","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.008_bib103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","article-title":"Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites","volume":"67","author":"Sinha","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib104","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.28318","article-title":"Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy\u00a0+ beta-blocker for prevention of variceal rebleeding","volume":"63","author":"Holster","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.008_bib105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.008_bib106","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/jhep.2002.30418","article-title":"TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial","volume":"35","author":"Escorsell","year":"2002","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820300246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820300246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:54:50Z","timestamp":1777510490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820300246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0168827820300246"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.01.008","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision medicine in variceal bleeding: Are we there yet?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}